The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 25, 2015
Filed:
Dec. 06, 2013
Applicant:
Immunovaccine Technologies, Inc., Halifax, CA;
Inventors:
Robert George Brown, Dartmouth, CA;
Bill Pohajdak, Dartmouth, CA;
Warwick Charles Kimmins, Halifax, CA;
Assignee:
IMMUNOVACCINE TECHNOLOGIES INC., Halifax—Nova Scotia, CA;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/00 (2006.01); A61K 39/39 (2006.01); A61K 9/127 (2006.01); A61K 47/44 (2006.01); A61K 39/29 (2006.01); A61K 39/04 (2006.01);
U.S. Cl.
CPC ...
A61K 47/44 (2013.01); A61K 9/127 (2013.01); A61K 39/00 (2013.01); A61K 39/04 (2013.01); A61K 39/292 (2013.01); A61K 39/39 (2013.01); A61K 2039/545 (2013.01); A61K 2039/5555 (2013.01); A61K 2039/55505 (2013.01); A61K 2039/55555 (2013.01); A61K 2039/55566 (2013.01); A61K 2039/575 (2013.01); C12N 2730/10134 (2013.01); Y10S 424/812 (2013.01); Y10S 514/937 (2013.01);
Abstract
The present invention is concerned with vaccines and their preparation. An effective long-term immune response, especially in mammals, can be produced using a vaccine comprising an antigen encapsulated in liposomes, a suitable adjuvant and a carrier comprising a continuous phase of a hydrophobic substance. The vaccine is particularly effective in eliciting the production of antibodies that recognize epitopes of native proteins.